Form 4: Twist Bioscience COO Patrick John Finn Reports Stock Transactions Following PSU Vesting

Patrick John Finn, COO of Twist Bioscience, reports the acquisition of shares through performance stock unit (PSU) vesting and subsequent sale of shares to cover tax obligations.

Summary

• On November 4, 2024, Patrick John Finn, the President and COO of Twist Bioscience, acquired shares of common stock due to the vesting of performance stock units (PSUs).
• The target criteria for these PSUs were met on the same date.
• A portion of the vested PSUs, specifically 60%, remains subject to time-based vesting and will vest on October 1, 2025, contingent upon continued service.
• Finn also sold 2,681 shares at a price of $41.564 per share to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• These sales were mandated by Twist Bioscience's equity incentive plans and are not considered discretionary trades.

Sentiment

Score: 6

Explanation: The document reports routine insider transactions related to stock vesting and tax obligations, which are neutral events. There is no indication of positive or negative sentiment.

Future Outlook

The remaining 60% of the PSUs will vest on October 1, 2025, subject to continued service.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the buying and selling activities of company executives and directors.

Stakeholder Impact

• The stock sale to cover tax obligations may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates